Revolution Medicines Inc (OQ:RVMD)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for RVMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Series C Convertible Preferred Stock C - Conversion    
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Series B Convertible Preferred Stock C - Conversion    
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Series A Convertible Preferred Stock C - Conversion    
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Common Stock C - Conversion    
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Series C Preferred Stock C - Conversion -99,758  
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Series B Preferred Stock C - Conversion -2,740,043  
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Series A Preferred Stock C - Conversion -5,137,583  
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Common Stock C - Conversion 7,977,384  
Feb 18/20 Feb 18/20 Flynn James E Indirect Ownership Series C Preferred Stock C - Conversion -498,795  
Feb 18/20 Feb 18/20 Flynn James E Indirect Ownership Series C Preferred Stock C - Conversion -997,589  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for RVMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Series C Convertible Preferred Stock C - Conversion    
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Series B Convertible Preferred Stock C - Conversion    
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Series A Convertible Preferred Stock C - Conversion    
Feb 20/20 Feb 18/20 Exter Neil Indirect Ownership Common Stock C - Conversion    
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Series C Preferred Stock C - Conversion -99,758  
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Series B Preferred Stock C - Conversion -2,740,043  
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Series A Preferred Stock C - Conversion -5,137,583  
Feb 18/20 Feb 18/20 Column Group Iii, Lp Direct Ownership Common Stock C - Conversion 7,977,384  
Feb 18/20 Feb 18/20 Flynn James E Indirect Ownership Series C Preferred Stock C - Conversion -498,795  
Feb 18/20 Feb 18/20 Flynn James E Indirect Ownership Series C Preferred Stock C - Conversion -997,589  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $RVMD

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)